Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

TriSalus Life Sciences (TLSI) Change in Taxes (2022 - 2023)

TriSalus Life Sciences has reported Change in Taxes over the past 2 years, most recently at -$24278.0 for Q2 2023.

For Q2 2023, Change in Taxes changed N/A year-over-year to -$24278.0; the TTM value through Jun 2023 reached $2492.0, changed N/A, while the annual FY2022 figure was $27854.0, N/A changed from the prior year.
Change in Taxes for Q2 2023 was -$24278.0 at TriSalus Life Sciences, down from $27118.0 in the prior quarter.
Over five years, Change in Taxes peaked at $135284.0 in Q3 2022 and troughed at -$135632.0 in Q4 2022.